Isoniazid is primarily used to treat active tuberculosis infections caused by Mycobacterium tuberculosis. It is also prescribed for latent TB infection (LTBI) to prevent the development of active TB disease. Additionally, it can be part of a combination therapy regimen to manage multidrug-resistant TB.
Isoniazid works by inhibiting mycolic acid synthesis in Mycobacterium tuberculosis. This disruption interferes with the bacterium's cell wall formation, leading to bacterial death. By targeting a specific enzyme called catalase-peroxidase (KatG), Isoniazid creates toxic compounds that damage the TB bacteria.
While effective in treating and preventing TB, Isoniazid can cause several side effects:
The dosage of Isoniazid depends on various factors such as age, weight, and severity of TB infection. Common dosages include:
It is crucial to follow the prescribed regimen strictly and complete the full course of treatment, even if symptoms improve before the end of therapy.
Isoniazid is often used in combination with other anti-TB drugs such as Rifampin, Ethambutol, and Pyrazinamide. These combinations enhance efficacy and reduce the risk of developing drug-resistant strains:
Drinking alcohol while taking Isoniazid is generally not recommended. Alcohol can increase the risk of liver damage, which is already a concern with this medication. It's best to avoid or limit alcohol consumption during treatment.
Pregnant women should use Isoniazid cautiously under medical supervision due to potential risks:
Isoniazid has a half-life of approximately 1-3 hours, but its effects can last longer. The drug is metabolized by the liver and excreted through urine. Complete elimination from the body may take several days.
For latent TB infection (LTBI), Isoniazid is often prescribed as a preventive treatment:
Isoniazid can interact with several medications, including:
Sudden discontinuation of Isoniazid can lead to relapse or worsening of TB symptoms. It is important to taper off the medication under medical supervision and only stop it as directed by a healthcare provider.
Isoniazid remains an essential tool in the fight against tuberculosis, offering effective treatment for both active and latent infections. However, its use requires careful management due to potential side effects and interactions with other medications. Always consult your healthcare provider before starting or adjusting Isoniazid therapy.